Search

everythinglearnresearchcommunity

for

Search:↓

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Trichoscopy can help diagnose and monitor the progression of dissecting cellulitis.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

The document suggests a possible link between Crohn's disease and Johne's disease and calls for more research.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

CEC levels may be a useful marker for predicting prostate cancer progression.

People with androgenetic alopecia often experience high stress, but the stress doesn't affect how the disease progresses or how well different treatments work.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Intravital imaging helps us better understand stem cells in their natural environment and could improve knowledge of organ regeneration and cancer development.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Trichoscopy helps diagnose and monitor hair and scalp problems without needing many biopsies.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Ultrasound is a useful, safe, and affordable tool for diagnosing and managing skin nodules.

Finasteride is effective and safe for long-term use in treating hair loss in Japanese men.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.